These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
Portfolio Pulse from Avi Kapoor
Elevance Health Inc. (NYSE:ELV) reported weaker-than-expected Q3 earnings, with a 21% drop in profit and adjusted EPS missing consensus estimates. Despite revenue growth, the company lowered its full-year guidance. Analysts have cut their price targets for ELV, reflecting concerns over its performance.
October 18, 2024 | 3:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Elevance Health reported weaker-than-expected Q3 earnings, with a significant drop in profit and adjusted EPS missing estimates. The company lowered its full-year guidance, and several analysts have reduced their price targets for ELV.
Elevance Health's Q3 earnings were below expectations, with a notable decline in profit and adjusted EPS. The company also reduced its full-year guidance, indicating potential challenges ahead. Analysts responded by lowering their price targets, suggesting a negative short-term outlook for the stock. The immediate market reaction was a 3.4% drop in share price, reflecting investor concerns.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100